MedTrace Logo

TU 025 Keishi Bukuryo Gan for Post-menopausal Hot Flash Management

NCT00119418 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2010-10-26

No results posted yet for this study

Summary

This study tests to see if TU 025 Keishi Bukuryo Gan reduces the frequency and severity of hot flashes in post-menopausal American women. This study will also estimate the best dose amount and determine the common short-term side effects and risks.

Conditions

Interventions

DRUG

TU 025 Keishi Bukuryo Gan

Sponsors & Collaborators

  • Tsumura and Company, Tokyo, Japan

    collaborator INDUSTRY

  • University of Minnesota

    collaborator OTHER

  • Plotnikoff, Gregory A., M.D.

    lead INDIV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
58 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-11-30
Completion
2006-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00119418 on ClinicalTrials.gov